NASDAQ:HRTX

Heron Therapeutics News Headlines

$18.07
+0.29 (+1.63 %)
(As of 04/21/2021 02:21 PM ET)
Add
Compare
Today's Range
$17.40
Now: $18.07
$18.07
50-Day Range
$14.49
MA: $16.61
$18.09
52-Week Range
$12.52
Now: $18.07
$22.40
Volume20,397 shs
Average Volume1.01 million shs
Market Capitalization$1.65 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.52

Headlines

Heron Therapeutics (NASDAQ HRTX) News Headlines Today

SourceHeadline
Heron Therapeutics (NASDAQ:HRTX) Trading Up 2.9%Heron Therapeutics (NASDAQ:HRTX) Trading Up 2.9%
americanbankingnews.com - April 20 at 2:44 PM
HRTX Jun 2021 15.000 callHRTX Jun 2021 15.000 call
ca.finance.yahoo.com - April 18 at 10:53 PM
HRTX Sep 2021 11.000 putHRTX Sep 2021 11.000 put
ca.finance.yahoo.com - April 18 at 10:53 PM
Financial Comparison: Heron Therapeutics (NASDAQ:HRTX) and OptiNose (NASDAQ:OPTN)Financial Comparison: Heron Therapeutics (NASDAQ:HRTX) and OptiNose (NASDAQ:OPTN)
americanbankingnews.com - April 12 at 2:12 AM
Heron Therapeutics (NASDAQ:HRTX) Shares Gap Down to $17.27Heron Therapeutics (NASDAQ:HRTX) Shares Gap Down to $17.27
americanbankingnews.com - April 9 at 11:34 AM
Do Options Traders Know Something About Heron Therapeutics (HRTX) Stock We Dont?Do Options Traders Know Something About Heron Therapeutics (HRTX) Stock We Don't?
msn.com - April 7 at 9:44 AM
HRTX Crosses Above Key Moving Average LevelHRTX Crosses Above Key Moving Average Level
nasdaq.com - April 6 at 1:01 PM
Head-To-Head Comparison: Zoetis (NYSE:ZTS) and Heron Therapeutics (NASDAQ:HRTX)Head-To-Head Comparison: Zoetis (NYSE:ZTS) and Heron Therapeutics (NASDAQ:HRTX)
americanbankingnews.com - April 4 at 2:12 PM
HERON THERAPEUTICS DL-,01 (AXD2.BE)HERON THERAPEUTICS DL-,01 (AXD2.BE)
in.finance.yahoo.com - March 21 at 11:22 AM
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate UpdatesHeron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates
finance.yahoo.com - February 24 at 9:30 AM
Analysts Estimate Heron Therapeutics (HRTX) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Heron Therapeutics (HRTX) to Report a Decline in Earnings: What to Look Out for
nasdaq.com - February 23 at 8:54 AM
How Much Did Heron Therapeutics(NASDAQ:HRTX) Shareholders Earn From Share Price Movements Over The Last Three Years?How Much Did Heron Therapeutics'(NASDAQ:HRTX) Shareholders Earn From Share Price Movements Over The Last Three Years?
finance.yahoo.com - February 21 at 1:40 PM
Heron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy SurgeryHeron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy Surgery
finance.yahoo.com - January 21 at 9:13 AM
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development ProgramHeron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program
finance.yahoo.com - January 11 at 10:31 AM
HRTX Jan 2021 21.000 putHRTX Jan 2021 21.000 put
ca.finance.yahoo.com - December 30 at 12:31 AM
HRTX Jan 2021 23.000 callHRTX Jan 2021 23.000 call
ca.finance.yahoo.com - December 30 at 12:31 AM
Heron Therapeutics (HRTX) Looks Good: Stock Adds 6.8% in SessionHeron Therapeutics (HRTX) Looks Good: Stock Adds 6.8% in Session
finance.yahoo.com - December 29 at 2:29 PM
HRTX Jan 2021 25.000 callHRTX Jan 2021 25.000 call
ca.finance.yahoo.com - December 27 at 11:02 PM
Heron Therapeutics (NASDAQ:HRTX) Has Debt But No Earnings; Should You Worry?Heron Therapeutics (NASDAQ:HRTX) Has Debt But No Earnings; Should You Worry?
finance.yahoo.com - December 23 at 8:08 AM
Is HRTX A Good Stock To Buy According To Hedge Funds?Is HRTX A Good Stock To Buy According To Hedge Funds?
finance.yahoo.com - December 19 at 5:31 PM
Heron Therapeutics: Huge Commercial Potential, But Not Out Of The Woods YetHeron Therapeutics: Huge Commercial Potential, But Not Out Of The Woods Yet
seekingalpha.com - November 16 at 3:32 PM
Heron Therapeutics resubmits US application for HTX-011 in postop painHeron Therapeutics resubmits US application for HTX-011 in postop pain
seekingalpha.com - November 13 at 11:18 AM
Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Treatment of Postoperative PainHeron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Treatment of Postoperative Pain
finance.yahoo.com - November 13 at 11:18 AM
Heron Therapeutics to Present at Several Upcoming Virtual Investor ConferencesHeron Therapeutics to Present at Several Upcoming Virtual Investor Conferences
finance.yahoo.com - November 11 at 8:12 PM
Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Released Its Third-Quarter Results And Analysts Are Updating Their EstimatesHeron Therapeutics, Inc. (NASDAQ:HRTX) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
finance.yahoo.com - November 8 at 12:58 PM
Heron Therapeutics EPS misses by $0.01, beats on revenueHeron Therapeutics EPS misses by $0.01, beats on revenue
seekingalpha.com - November 5 at 12:01 PM
Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended  September 30, 2020 and Highlights Recent Corporate UpdatesHeron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2020 and Highlights Recent Corporate Updates
finance.yahoo.com - November 5 at 12:01 PM
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseHeron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
finance.yahoo.com - November 3 at 5:36 PM
7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio
finance.yahoo.com - October 31 at 9:19 AM
Heron Therapeutics, Inc.s (NASDAQ:HRTX) Shift From Loss To ProfitHeron Therapeutics, Inc.'s (NASDAQ:HRTX) Shift From Loss To Profit
finance.yahoo.com - October 21 at 2:44 PM
Herons Zynrelef OKd in Europe for post-op painHeron's Zynrelef OK'd in Europe for post-op pain
seekingalpha.com - September 28 at 1:34 PM
Heron Therapeutics HTX-011 shows positive action in hernia repair surgeryHeron Therapeutics' HTX-011 shows positive action in hernia repair surgery
seekingalpha.com - September 16 at 1:19 PM
Heron Therapeutics HTX-011 shows positive action in herniorrhaphyHeron Therapeutics' HTX-011 shows positive action in herniorrhaphy
seekingalpha.com - September 16 at 1:19 PM
Heron Therapeutics Announces Publication of Results from EPOCH 2 Follow-On Study, a Phase 2b Study of HTX-011 in Patients Undergoing Hernia Repair SurgeryHeron Therapeutics Announces Publication of Results from EPOCH 2 Follow-On Study, a Phase 2b Study of HTX-011 in Patients Undergoing Hernia Repair Surgery
finance.yahoo.com - September 16 at 1:19 PM
Heron Therapeutics to Present at Cantor Virtual Global Healthcare ConferenceHeron Therapeutics to Present at Cantor Virtual Global Healthcare Conference
finance.yahoo.com - September 11 at 5:53 PM
Stock Alert: Heron Therapeutics Shares Up 8%Stock Alert: Heron Therapeutics Shares Up 8%
markets.businessinsider.com - September 8 at 1:57 PM
Heron Announces Alignment With FDA On Next Steps For HTX-011 NDA ResubmissionHeron Announces Alignment With FDA On Next Steps For HTX-011 NDA Resubmission
nasdaq.com - September 8 at 1:57 PM
How Much Did Heron Therapeutics (NASDAQ:HRTX) CEO Pocket Last Year?How Much Did Heron Therapeutics' (NASDAQ:HRTX) CEO Pocket Last Year?
finance.yahoo.com - August 29 at 1:54 PM
How Much Did Heron Therapeutics' (NASDAQ:HRTX) CEO Pocket Last Year?How Much Did Heron Therapeutics' (NASDAQ:HRTX) CEO Pocket Last Year?
finance.yahoo.com - August 29 at 1:54 PM
Why Heron Therapeutics Stock Popped in JulyWhy Heron Therapeutics Stock Popped in July
fool.com - August 10 at 10:56 AM
Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue EstimatesHeron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 5 at 9:57 PM
Did Hedge Funds Make The Right Call On Heron Therapeutics Inc (HRTX) ?Did Hedge Funds Make The Right Call On Heron Therapeutics Inc (HRTX) ?
finance.yahoo.com - August 4 at 2:50 PM
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
finance.yahoo.com - July 27 at 1:25 PM
European advisory group backs Heron drug for post-op painEuropean advisory group backs Heron drug for post-op pain
seekingalpha.com - July 24 at 12:54 PM
Heron Therapeutics (NASDAQ:HRTX) Stock Price Has Reduced48% In The Past Five YearsHeron Therapeutics' (NASDAQ:HRTX) Stock Price Has Reduced48% In The Past Five Years
finance.yahoo.com - July 24 at 12:54 PM
Heron Therapeutics' (NASDAQ:HRTX) Stock Price Has Reduced48% In The Past Five YearsHeron Therapeutics' (NASDAQ:HRTX) Stock Price Has Reduced48% In The Past Five Years
finance.yahoo.com - July 24 at 12:54 PM
Herons Cinvanti Progress, And Other News: The Good, Bad And Ugly Of BiopharmaHeron's Cinvanti Progress, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - July 16 at 11:14 PM
Heron Therapeutics Announces Initiation of Phase 2 Clinical Study of CINVANTI® for the Treatment of COVID-19Heron Therapeutics Announces Initiation of Phase 2 Clinical Study of CINVANTI® for the Treatment of COVID-19
finance.yahoo.com - July 16 at 1:13 PM
U.S. FDA again declines to approve Heron Therapeutics non-opioid painkillerU.S. FDA again declines to approve Heron Therapeutics' non-opioid painkiller
www.nasdaq.com - July 1 at 6:39 PM
Herons Pain Management Drug Gets Complete Response LetterHeron's Pain Management Drug Gets Complete Response Letter
www.nasdaq.com - June 30 at 2:06 PM
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.